different glp-1 agonists PDB-101: Molecule of the Month: Receptor The Landscape Of GLP-1 Receptor
Description
In clinical trials, people using GLP-1 drugs lost an average of about 10 pounds more than people using a placebo
This is the unlikely journey from desert predator to medical marvel.
All Day
People generally report mild to no pain with the injection
Engineering new ligands that specifically target multiple G protein-coupled receptors with desired activity profiles requires time-consuming and expensive cycles of design-make-test-analyse work
Learn how GLP-1 medications may affect vision, from blurry sight to rare risks, plus potential eye health benefits and when to see an eye doctor.
